RICTOR and cancer: Many studies have demonstrated that patients with a high expression of RICTOR in tumor tissue samples have a lower overall survival in cancers, such as small cell lung cancer, colorectal cancer and esophageal squamous cell carcinoma (Fig. 2b-d).